Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania

被引:41
作者
Correa, Cristiane
Amboni, Graziela
Assis, Lara Clemes
Martins, Marcio R.
Kapczinski, Flavio
Streck, Emilio L. [1 ]
Quevedo, Joao
机构
[1] Univ Extremo Sul Catarinense, Lab Fisiopatol Expt, BR-88806000 Criciuma, SC, Brazil
[2] Univ Extremo Sul Catarinense, Lab Neurociencias, BR-88806000 Criciuma, SC, Brazil
[3] Hosp Clin Porto Alegre, Bipolar Disorders Program, BR-90035003 Porto Alegre, RS, Brazil
关键词
amphetamine; bipolar disorder; citrate synthase; lithium; mania; valproate;
D O I
10.1016/j.pnpbp.2007.02.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Some studies suggest that mitochondrial dysfunction may be related to the pathophysiology of bipolar disorder. In this work, we evaluated the activity of citrate synthase in rats, and the effects of the treatment with mood stabilizers (lithium and valproate) on the enzyme activity. In the first experiment (reversal treatment), amphetamine or saline were administered to rats for 14 days, and between day 8 and 14, rats were treated with either lithium, valproate or saline. In the second experiment (prevention treatment), rats were pretreated with lithium, valproate or saline, and between day 8 and 14, rats were administered amphetamine or saline. In reversal and prevention models, amphetamine administration significantly inhibited citrate synthase activity in rat hippocampus. In amphetamine-pretreated animals, valproate administration reversed citrate synthase activity inhibition induced by amphetamine. In the prevention model, pretreatment with lithium prevented amphetamine-induced citrate synthase inhibition. Our results showed that amphetamine inhibited citrate synthase activity and that valproate reversed and lithium prevented the enzyme inhibition. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:887 / 891
页数:5
相关论文
共 42 条
[1]   Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients [J].
Anand, A ;
Verhoeff, P ;
Seneca, N ;
Zoghbi, SS ;
Seibyl, JP ;
Charney, DS ;
Innis, RB .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (07) :1108-1114
[2]   Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade [J].
Beaulieu, JM ;
Sotnikova, TD ;
Yao, WD ;
Kockeritz, L ;
Woodgett, JR ;
Gainetdinov, RR ;
Caron, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) :5099-5104
[3]   Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation [J].
Bell, EC ;
Willson, MC ;
Wilman, AH ;
Dave, S ;
Asghar, SJ ;
Silverstone, PH .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (02) :87-96
[4]   Medical progress: Bipolar disorder [J].
Belmaker, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :476-486
[5]   Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss [J].
Bersudsky, Yuly ;
Shaldubina, Alona ;
Belmaker, R. H. .
BEHAVIOURAL PHARMACOLOGY, 2007, 18 (01) :77-80
[6]   Neuronal pathology in the hippocampal area of patients with bipolar disorder: A study with proton magnetic resonance spectroscopic imaging [J].
Bertolino, A ;
Frye, M ;
Callicott, JH ;
Mattay, VS ;
Rakow, R ;
Shelton-Repella, J ;
Post, R ;
Weinberger, DR .
BIOLOGICAL PSYCHIATRY, 2003, 53 (10) :906-913
[7]   The neurobiology of bipolar disorder: Focus on signal transduction pathways and the regulation of gene expression [J].
Bezchlibnyk, Y ;
Young, LT .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (02) :135-148
[8]   Mitochondrial involvement in brain function and dysfunction: Relevance to aging, neurodegenerative disorders and longevity [J].
Calabrese, V ;
Scapagnini, G ;
Stella, AMG ;
Bates, TE ;
Clark, JB .
NEUROCHEMICAL RESEARCH, 2001, 26 (06) :739-764
[9]   Neuroprotective effects of lithium in cultured cells and animal models of diseases [J].
Chuang, DM ;
Chen, RW ;
Chalecka-Franaszek, E ;
Ren, M ;
Hashimoto, R ;
Senatorov, V ;
Kanai, H ;
Hough, C ;
Hiroi, T ;
Leeds, P .
BIPOLAR DISORDERS, 2002, 4 (02) :129-136
[10]   Finding the intracellular signaling pathways affected by mood disorder treatments [J].
Coyle, JT ;
Duman, RS .
NEURON, 2003, 38 (02) :157-160